Skip to main content
. 2022 Oct 26;8:427. doi: 10.1038/s41420-022-01218-8

Fig. 5. Role of ferroptosis on cancer immunotherapy.

Fig. 5

Ferroptosis induction facilitates MCH-1 expression, release of DAMPS and IFNγ, which in turn activate immune cell activity including T cells and macrophages. In addition, the release of IFNγ from T cells inhibits Xc (-) system (SLC7A11/SLC3A2), leading to increased ferroptosis sensitivity. Ferroptosis resistance by GPX4 in Treg cells causes immune tolerance. As an eat-me signal, SAPE-OOH is distributed on ferroptotic cancer cells, which is recognized by TLR2 on macrophages leading to increased phagocytosis. Although combined immune checkpoint inhibitors with ferroptosis inducers could effectively enhance antitumor immunotherapy, induction of ferroptosis could impair T cell survival by ferroptosis. Therefore, a rational combined therapy is essential.